| Market Cap | ₹92,558Cr |
| ROE | 19.44% |
| P/E Ratio(TTM) | 18.40 |
| EPS(TTM) | 49.98 |
| P/B Ratio | 3.66 |
| Dividend Yield | 1.20% |
| Industry P/E | 33.07 |
| Book Value | 251.45 |
| Debt to Equity | 0.38 |
| Face Value | 1 |
| Parent Organisation | Zydus Lifesciences |
| Managing Director | Dr. Sharvil P. Patel |
| Founded | 1995 |
| NSE Symbol | ZYDUSLIFE |
| COMPANY | 52 WEEK | MARKET PRICE | P/E Ratio | |
|---|---|---|---|---|
| Sun Pharmaceutical Industries | NA (0.00%) | 39.93 | ||
| Cipla | NA (0.00%) | 22.55 | ||
| Dr Reddy's Laboratories | NA (0.00%) | 18.60 | ||
| Lupin | NA (0.00%) | 22.34 |